02/21/2026
We're live at ACNS 2026 👋
Team is onsite at the American Clinical Neurophysiology Society (ACNS) Conference in New Orleans, LA, through the weekend!
Since introducing the first FDA-cleared MR Conditional EEG Electrodes to market in 2012, Rhythmlink has continued to set the standard in MR Conditional electrode manufacturing. With more than 30 million electrodes placed and 12 years of market leadership, our solutions are trusted by leading neurology institutions nationwide.
Visit Kevin and Tom at 𝗕𝗼𝗼𝘁𝗵 #𝟭𝟬𝟯 to learn more about our MR Conditional portfolio!
We look forward to connecting with you.